Do Your Research

Ep 144: Biogen's (BIIB) FDA Approval


Listen Later

It's Monday, June 7th, 2021. I'm Hoda, Co-founder and CEO of Stock Card. This is what happened in the stock market today.


I reviewed how investors' sentiment held the market back for one more day and announced an exciting new feature on Stock Card. I also covered the major Alzheimer drug news that launched Biogen’s (#BIIB) stock and investigated a slight dip in UiPath’s (#PATH) price in advance of its first earnings report.


 


👉 Here's the list of companies reporting their earnings this week  


 


👉 If you haven't signed up for a free Stock Card account, don't forget to sign up today



👉 By the way, neither I nor Stock Card, Inc. is a broker, a dealer, or a registered investment adviser, nor operated by either. Under no circumstances does any information posted on The Daily Market Recap or Stock Card's website and communications represent a recommendation to buy or sell a security. For more information, refer to our Terms of Use, Privacy Policy, and Disclosure Policy on the footer of our website: https://stockcard.io/



This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit hodamehr.substack.com
...more
View all episodesView all episodes
Download on the App Store

Do Your ResearchBy Hoda Mehr

  • 4.3
  • 4.3
  • 4.3
  • 4.3
  • 4.3

4.3

6 ratings